Cargando…
Comparing the Synergistic and Antagonistic Interactions of Ciprofloxacin and Levofloxacin Combined with Rifampin against Drug-Resistant Staphylococcus aureus: A Time–Kill Assay
Background: Treatment of device-related infections by drug-resistant Staphylococcus aureus can be challenging, and combination therapy has been proposed as a potential solution. We compared the effectiveness of levofloxacin–rifampin and ciprofloxacin–rifampin combinations in killing methicillin-resi...
Autores principales: | Kang, Yu Ri, Chung, Doo Ryeon, Ko, Jae-Hoon, Huh, Kyungmin, Cho, Sun Young, Kang, Cheol-In, Peck, Kyong Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135007/ https://www.ncbi.nlm.nih.gov/pubmed/37107077 http://dx.doi.org/10.3390/antibiotics12040711 |
Ejemplares similares
-
Role of echocardiography in uncomplicated Staphylococcus aureus catheter-related bloodstream infections
por: Mun, Seok Jun, et al.
Publicado: (2021) -
Impact of vancomycin use trend change due to the availability of alternative antibiotics on the prevalence of Staphylococcus aureus with reduced vancomycin susceptibility: a 14-year retrospective study
por: Kang, Yu Ri, et al.
Publicado: (2022) -
Comparison of Staphylococcus aureus tolerance between antimicrobial blue light, levofloxacin, and rifampin
por: Ong, Jemi, et al.
Publicado: (2023) -
Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis
por: Joo, Eun-Jeong, et al.
Publicado: (2019) -
Clinical Impact of Revised Ciprofloxacin Breakpoint in Patients with Urinary Tract Infections by Enterobacteriaceae
por: Park, Ga Eun, et al.
Publicado: (2021)